Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy.

作者: Andrew W. Winslow , Joseph C. Turbyville , J. Wesley Sublett , James L. Sublett , Stephen J. Pollard

DOI: 10.1016/J.ANAI.2016.09.005

关键词:

摘要: Abstract Background Given the choice of standard, cluster, and rush build-up for aeroallergen immunotherapy, standard-build immunotherapy has generally been preferred because a perceived high rate systemic reactions (SRs) associated with cluster immunotherapy. Objective To characterize incidence SRs during in an allergy practice 5-year period. Methods A retrospective review was conducted among patients receiving standard-build, 8- to 10-step or 2-day from January 1, 2010, through December 31, 2014, at Family Allergy & Asthma clinics Louisville, Kentucky. Investigators excluded that occurred skin prick testing, venom not-true SRs, identified method, age, sex, date reaction, vial concentration, presence asthma. Per-shot per-patient computed these data. Results During our period, 2,549,643 injections were administered 11,982 patients. SR 0.01%, 0.06%, 0.33% respectively; 2.84%, 2.52%, 11.86% respectively. total 42% grade 43% 2, 12% 3, 3% 4. No fatalities reported. 70% 75% SR, 55% females, emergent peak May October. Conclusion Compared previously published rates, we observed decrease seasonality October female predominance.

参考文章(10)
Viviana M. Temiño, Pingsheng Wu, Janet Konig, John M. Fahrenholz, Safety of multiple aeroallergen rush immunotherapy using a modified schedule. Allergy and Asthma Proceedings. ,vol. 34, pp. 255- 260 ,(2013) , 10.2500/AAP.2013.34.3651
Daniel R. More, Larry L. Hagan, Factors affecting compliance with allergen immunotherapy at a military medical center. Annals of Allergy Asthma & Immunology. ,vol. 88, pp. 391- 394 ,(2002) , 10.1016/S1081-1206(10)62370-8
Christopher C. Copenhaver, Anne Parker, Steven Patch, Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice. Annals of Allergy Asthma & Immunology. ,vol. 107, pp. 441- 447 ,(2011) , 10.1016/J.ANAI.2011.06.026
Alfredo Iglesias-Cadarso, Pilar Hernández-Weigand, Risk factors for systemic reactions to allergen immunotherapy. Current Opinion in Allergy and Clinical Immunology. ,vol. 11, pp. 579- 585 ,(2011) , 10.1097/ACI.0B013E32834C229E
Linda Cox, Harold Nelson, Richard Lockey, Christopher Calabria, Thomas Chacko, Ira Finegold, Michael Nelson, Richard Weber, David I. Bernstein, Joann Blessing-Moore, Allergen immunotherapy: A practice parameter third update Journal of Allergy and Clinical Immunology. ,vol. 127, pp. S1- S55 ,(2011) , 10.1016/J.JACI.2010.09.034
Linda Cox, Desiree Larenas-Linnemann, Richard F. Lockey, Giovanni Passalacqua, Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System Journal of Allergy and Clinical Immunology. ,vol. 125, pp. 569- 574.e7 ,(2010) , 10.1016/J.JACI.2009.10.060
Christopher W. Calabria, Accelerated Immunotherapy Schedules Current Allergy and Asthma Reports. ,vol. 13, pp. 389- 398 ,(2013) , 10.1007/S11882-013-0356-X
Eli O. Meltzer, Kerstin Malmstrom, Susan Lu, Bruce M. Prenner, Lynn X. Wei, Steven F. Weinstein, James D. Wolfe, Theodore F. Reiss, Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial The Journal of Allergy and Clinical Immunology. ,vol. 105, pp. 917- 922 ,(2000) , 10.1067/MAI.2000.106040
Tolly G. Epstein, Gary M. Liss, Karen Murphy-Berendts, David I. Bernstein, Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy : National surveillance study on allergen immunotherapy (2008–2013) Annals of Allergy Asthma & Immunology. ,vol. 116, pp. 354- 359 ,(2016) , 10.1016/J.ANAI.2016.02.001